These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17549050)

  • 1. Double pharmacological challenge on repolarization opens new avenues for drug safety research.
    Thomsen MB
    Br J Pharmacol; 2007 Aug; 151(7):909-11. PubMed ID: 17549050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.
    Orosz S; Sarusi A; Csík N; Papp JG; Varró A; Farkas S; Forster T; Farkas AS; Farkas A
    J Cardiovasc Pharmacol; 2014 Sep; 64(3):266-76. PubMed ID: 24887684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition of key potassium currents has different effects on cardiac repolarization reserve and arrhythmia susceptibility in dogs and rabbits.
    Husti Z; Tábori K; Juhász V; Hornyik T; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2015 Jul; 93(7):535-44. PubMed ID: 25928472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.
    Michael G; Dempster J; Kane KA; Coker SJ
    Br J Pharmacol; 2007 Dec; 152(8):1215-27. PubMed ID: 17965747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
    Lawrence CL; Pollard CE; Hammond TG; Valentin JP
    J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenaline reveals the torsadogenic effect of combined blockade of potassium channels in anaesthetized guinea pigs.
    Michael G; Kane KA; Coker SJ
    Br J Pharmacol; 2008 Aug; 154(7):1414-26. PubMed ID: 18493252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
    Said TH; Wilson LD; Jeyaraj D; Fossa AA; Rosenbaum DS
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):165-71. PubMed ID: 22561361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.
    Hanson LA; Bass AS; Gintant G; Mittelstadt S; Rampe D; Thomas K
    J Pharmacol Toxicol Methods; 2006; 54(2):116-29. PubMed ID: 16843688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig.
    Guns PJ; Johnson DM; Weltens E; Lissens J
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):125-34. PubMed ID: 22516473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.
    Farkas AS; Nattel S
    Drugs; 2010 Mar; 70(5):573-603. PubMed ID: 20329805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs.
    Pham TV; Sosunov EA; Gainullin RZ; Danilo P; Rosen MR
    Circulation; 2001 May; 103(17):2207-12. PubMed ID: 11331264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of QT interval assessment in safety pharmacology.
    Lacroix P; Picard S
    Curr Protoc Pharmacol; 2006 Jul; Chapter 10():Unit10.7. PubMed ID: 22294169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
    Guérard NC; Traebert M; Suter W; Dumotier BM
    J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo.
    Varkevisser R; Wijers SC; van der Heyden MA; Beekman JD; Meine M; Vos MA
    Heart Rhythm; 2012 Oct; 9(10):1718-26. PubMed ID: 22609158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.